tradingkey.logo

TELA Bio Inc

TELA
0.811USD
+0.011+1.35%
Close 02/06, 16:00ETQuotes delayed by 15 min
32.71MMarket Cap
LossP/E TTM

TELA Bio Inc

0.811
+0.011+1.35%

More Details of TELA Bio Inc Company

TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall reconstruction. Its OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair. The Company's OviTex products include OviTex 1S, OviTex 2S, OviTex LPR, and OviTex IHR. Its second portfolio of products, the OviTex PRS Reinforced Tissue Matrix (OviTex PRS), addresses unmet needs in plastic and reconstructive surgery. OviTex PRS is indicated for use in implantation to reinforce soft tissue where weakness exists in patients requiring soft-tissue repair.

TELA Bio Inc Info

Ticker SymbolTELA
Company nameTELA Bio Inc
IPO dateNov 08, 2019
CEOKoblish (Antony)
Number of employees209
Security typeOrdinary Share
Fiscal year-endNov 08
Address1 Great Valley Parkway, Suite 24
CityMALVERN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code19355
Phone14843202930
Websitehttps://www.telabio.com/
Ticker SymbolTELA
IPO dateNov 08, 2019
CEOKoblish (Antony)

Company Executives of TELA Bio Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-93591.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+104800.00%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-23535.00%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+7950.00%
Dr. Betty Jo Rocchio
Dr. Betty Jo Rocchio
Independent Director
Independent Director
11.93K
+11925.00%
Mr. Vince J. Burgess
Mr. Vince J. Burgess
Independent Director
Independent Director
--
--
Mr. Roberto E. Cuca, J.D.
Mr. Roberto E. Cuca, J.D.
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Mr. Greg Firestone
Mr. Greg Firestone
Chief Commercial Officer
Chief Commercial Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Antony Koblish
Mr. Antony Koblish
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
339.79K
-93591.00%
Mr. Jeffrey (Jeff) Blizard
Mr. Jeffrey (Jeff) Blizard
President
President
112.75K
+104800.00%
Mr. Paul Talmo
Mr. Paul Talmo
Chief Technology Officer
Chief Technology Officer
61.37K
-23535.00%
Ms. Federica F. O'Brien
Ms. Federica F. O'Brien
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Kurt Azarbarzin
Mr. Kurt Azarbarzin
Independent Director
Independent Director
14.22K
+7950.00%
Mr. Douglas G. (Doug) Evans
Mr. Douglas G. (Doug) Evans
Independent Chairman of the Board
Independent Chairman of the Board
14.22K
+7950.00%

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
By BusinessUSD
Name
Revenue
Proportion
OviTex
25.32M
64.56%
OviTex PRS
13.12M
33.47%
Other
771.00K
1.97%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
OviTex
25.32M
64.56%
OviTex PRS
13.12M
33.47%
Other
771.00K
1.97%

Shareholding Stats

Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
Other
49.38%
Shareholders
Shareholders
Proportion
EW Healthcare Partners
17.62%
Nantahala Capital Management, LLC
11.68%
North Run Capital, LP
8.41%
Lytton (Laurence W)
6.55%
SilverArc Capital Management, LLC
6.36%
Other
49.38%
Shareholder Types
Shareholders
Proportion
Hedge Fund
33.24%
Venture Capital
17.62%
Investment Advisor
14.30%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
8.53%
Research Firm
1.77%
Other
15.87%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
161
33.13M
75.68%
-6.50M
2025Q3
171
28.74M
72.54%
-9.88M
2025Q2
185
33.40M
84.44%
-6.87M
2025Q1
191
33.22M
84.09%
-7.97M
2024Q4
187
31.75M
80.76%
+976.11K
2024Q3
178
22.55M
84.95%
-6.37M
2024Q2
170
20.61M
83.03%
-5.54M
2024Q1
157
22.19M
89.70%
-5.95M
2023Q4
151
21.96M
89.44%
-4.89M
2023Q3
146
22.32M
90.91%
-4.91M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
EW Healthcare Partners
7.71M
17.62%
+3.60M
+87.67%
Nov 17, 2025
Nantahala Capital Management, LLC
5.11M
11.68%
--
--
Sep 30, 2025
North Run Capital, LP
3.68M
8.41%
+1.70M
+85.75%
Mar 31, 2025
Lytton (Laurence W)
2.87M
6.55%
+141.11K
+5.18%
Sep 30, 2025
SilverArc Capital Management, LLC
2.78M
6.36%
+3.13K
+0.11%
Sep 30, 2025
Stonepine Capital Management, LLC
2.16M
4.92%
+71.76K
+3.44%
Sep 30, 2025
The Vanguard Group, Inc.
1.80M
4.11%
-111.69K
-5.84%
Sep 30, 2025
UBS Financial Services, Inc.
216.80K
0.5%
-28.75K
-11.71%
Sep 30, 2025
Dafna Capital Management, LLC
1.44M
3.29%
--
--
Sep 30, 2025
Perkins Capital Management, Inc.
833.93K
1.91%
-41.94K
-4.79%
Sep 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
iShares Micro-Cap ETF
Proportion0.01%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
Proshares Ultra Russell 2000
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI